Featured Bioprocessing Editorial

1. Exploring Takeda's Template For Sustainable Steam Generation 7/17/2026

   Takeda designed a model for delivering steam at 11 bar and up to 184 degrees using natural refrigerant and waste heat at one of its largest production sites.

2. Addressing The Particulate Challenge In Cell Therapy Products 7/15/2026

   Cell therapy products challenge traditional particulate controls. One expert explains detection, mitigation, and contamination prevention.

3. Let's Stop Treating Allogeneic Cell Therapy As One Thing 7/14/2026

   Industry is beginning to accept that allogeneic cell therapy spans categories, and success depends on aligning biology, regulation, and economics unique to each product.

4. Allogeneic Cell Therapy Is Still Learning What Biology Will Allow 7/14/2026

   Allogeneic cell therapy is advancing through smarter donor selection and manufacturing control, showing how biology, process design, and product consistency drive success.

5. Top 5 Challenges In Antibody-Oligonucleotide Manufacturing 7/10/2026

   AOC manufacturing breaks programs in five predictable ways. Learn where antibody-oligonucleotide conjugate development stalls, from synthesis impurities to conjugation chemistry, and what preparation actually looks like.

6. Transforming Computer System Validation In The Life Sciences Industry 7/10/2026

   Regulators acknowledge how traditional CSV methods fail to meet modern demands for speed and flexibility. The scene is changing in favor of smarter, leaner validation.

7. Analyzing And Managing CDMO Project Risks Using Causal Mechanism & Effect Analysis 7/8/2026

   Since every sponsor–CDMO relationship can have widely different scopes, requirements, and procedures, this article focuses on the basic principles for analyzing and managing the risks of not achieving the relationship’s objectives.

8. Achieving Annex 1 Compliance In Sterile Manufacturing, Part 3: Building A Compliant Program 7/7/2026

   In this third and final article of this series, let's take a closer look at what a well-constructed Annex 1-compliant program looks like at each stage, from gap assessment through governance.

9. An Open-Source Modeling Tool For Suspended Continuous Lyophilization 7/7/2026

   Building on a continuous suspended-vial lyophilization workflow, process developers can model critical variables before doing physical experiments.

10. Mapping Early-Phase Supply Chain Bottlenecks That Doom Pipelines 6/30/2026

    Many sponsors miscast preclinical development as an unglamorous step between discovery and the clinic. Here's how the consequences may lead to irrevocable losses.